Insulet
PODD
#2041
Rank
A$13.85 B
Marketcap
A$199.79
Share price
-3.46%
Change (1 day)
-62.56%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): A$0.88 Billion

According to Insulet's latest financial reports the company's current earnings are A$3.18 Billion. In 2025 the company made an earning of A$0.60 Billion, an increase over its 2024 earnings that were of A$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.88 B47.25%
2025 A$0.60 B16.3%
2024 A$0.51 B36.76%
2023 A$0.37 B481.9%
2022 A$64.99 M-45.24%
2021 A$0.11 B43.35%
2020 A$82.78 M18.51%
2019 A$69.86 M41.16%
2018 A$49.49 M-711.95%
2017 -A$8.09 Million-56.85%
2016 -A$18.75 Million-79.31%
2015 -A$90.61 Million63.85%
2014 -A$55.3 Million31.04%
2013 -A$42.21 Million-21.96%
2012 -A$54.08 Million
2010 -A$51.58 Million-42.38%
2009 -A$89.52 Million-33.56%
2008 -A$0.14 Billion65.93%
2007 -A$81.2 Million209.75%
2006 -A$26.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.23 B 2,977.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.88 B 1,086.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$11.05 B 1,104.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$52.43 B 5,614.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$91.99 Million-110.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.12 B-86.38%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.92 B 109.70%๐Ÿ‡บ๐Ÿ‡ธ USA